15 fév 2025 |
|
|
Samsung Bioepis Co., Ltd. today announced that the European Commission (EC) has granted marketing authorization for OBODENCEtm (60mg pre-filled syringe) and XBRYKtm (120mg vial), denosumab biosimilars referencing Prolia and Xgeva ? formerly referred...
|
15 fév 2025 |
|
|
Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today presented new data for casdatifan, a HIF-2a inhibitor with...
|
15 fév 2025 |
|
|
Product: Fried Falafel with Tahini Sauce
Issue: Food - Allergen - Peanut
Distribution: Alberta Newfoundland and Labrador Ontario
See the affected products and product photos for this recall...
|
15 fév 2025 |
|
|
Exelixis, Inc. today announced final results from the phase 3 CheckMate -9ER pivotal trial evaluating CABOMETYX® (cabozantinib) in combination with Opdivo® (nivolumab) versus sunitinib for patients with previously untreated advanced renal cell...
|
15 fév 2025 |
|
|
For children with high threshold peanut allergy, oral immunotherapy using store-bought and home-measured peanut products provided significantly higher rates of desensitization compared to peanut avoiders, according to new research being presented at...
|
15 fév 2025 |
|
|
LifeNet Health proudly announces the launch of OraGen®, the first viable dental bone allograft comprised of cryopreserved corticocancellous bone containing endogenous lineage-committed bone cells combined with demineralized bone matrix. This unique...
|
|
|